ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HVO Hvivo Plc

28.75
0.25 (0.88%)
Last Updated: 08:00:05
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hvivo Plc LSE:HVO London Ordinary Share GB00B9275X97 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 0.88% 28.75 28.50 29.00 28.75 28.75 28.75 140,122 08:00:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 48.48M -776k -0.0011 -261.36 194.08M

hVIVO plc Form 8 (OPD) (4281W)

11/12/2019 7:00am

UK Regulatory


Hvivo (LSE:HVO)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Hvivo Charts.

TIDMHVO TIDMORPH

RNS Number : 4281W

hVIVO plc

11 December 2019

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

   1.         KEY INFORMATION 
 
 (a) Full name of discloser:                                                 hVIVO plc ("hVIVO") 
 (b) Owner or controller of interests and short positions disclosed, if      n/a 
 different from 1(a): 
 The naming of nominee or vehicle companies is insufficient. For a trust, 
 the trustee(s), 
 settlor and beneficiaries must be named. 
                                                                            ------------------------------------------ 
 (c) Name of offeror/offeree in relation to whose relevant securities this   Open Orphan Plc ("Open Orphan") (offeror) 
 form relates: 
 Use a separate form for each offeror/offeree 
                                                                            ------------------------------------------ 
 (d) Is the discloser the offeror or the offeree?                            OFFEREE 
                                                                            ------------------------------------------ 
 (e) Date position held:                                                     06/12/2019 
  The latest practicable date prior to the disclosure 
                                                                            ------------------------------------------ 
 (f) In addition to the company in 1(c) above, is the discloser making       YES - hVIVO plc 
 disclosures in respect 
 of any other party to the offer? 
 If it is a cash offer or possible cash offer, state "N/A" 
                                                                            ------------------------------------------ 
 
   2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 
 Class of relevant security: 
                                                                                       Interests      Short positions 
                                                                                     -------------  ------------------ 
                                                                                      Number    %      Number      % 
                                                                                     -------  ----  -----------  ----- 
 (1) Relevant securities owned and/or controlled:                                      Nil     Nil      Nil       Nil 
                                                                                     -------  ----  -----------  ----- 
 (2) Cash-settled derivatives:                                                         Nil     Nil      Nil       Nil 
                                                                                     -------  ----  -----------  ----- 
 (3) Stock-settled derivatives (including options) and agreements to purchase/sell:    Nil     Nil      Nil       Nil 
                                                                                     -------  ----  -----------  ----- 
                                                                                       Nil     Nil      Nil       Nil 
   TOTAL: 
                                                                                     -------  ----  -----------  ----- 
 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

   (b)        Rights to subscribe for new securities 
 
 Class of relevant security in relation to which subscription right exists:    Nil 
 Details, including nature of the rights concerned and relevant percentages:   Nil 
                                                                              ---- 
 
   3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE 
 
 Details of any interests, short positions and rights to subscribe (including directors' and 
  other employee options) of any person acting in concert with the party to the offer making 
  the disclosure: 
 
   Interests of hVIVO Directors in Open Orphan shares: Name            No. of shares   % 
    Dr Mark Warne   2,543*          <0.1 
                   --------------  ----- 
 
   *These Open Orphan shares are held in Dr Mark Warne's account with Interactive Investors Nominees 
   Limited 
 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

   4.         OTHER INFORMATION 
   (a)        Indemnity and other dealing arrangements 
 
 Details of any indemnity or option arrangement, or any agreement or understanding, formal 
  or informal, relating to relevant securities which may be an inducement to deal or refrain 
  from dealing entered into by the party to the offer making the disclosure or any person acting 
  in concert with it: 
  Irrevocable commitments and letters of intent should not be included. If there are no such 
  agreements, arrangements or understandings, state "none" 
 
   None 
 
   (b)        Agreements, arrangements or understandings relating to options or derivatives 
 
 Details of any agreement, arrangement or understanding, formal or informal, between the party 
  to the offer making the disclosure, or any person acting in concert with it, and any other 
  person relating to: 
  (i) the voting rights of any relevant securities under any option; or 
  (ii) the voting rights or future acquisition or disposal of any relevant securities to which 
  any derivative is referenced: 
  If there are no such agreements, arrangements or understandings, state "none" 
 
   None 
 
   (c)        Attachments 

Are any Supplemental Forms attached?

 
 Supplemental Form 8 (Open Positions)   NO 
 Supplemental Form 8 (SBL)              NO 
                                       --- 
 
 
 Date of disclosure:    11/12/2019 
 Contact name:          Anesh Patel (Interim Finance Director & Company Secretary) 
                       ----------------------------------------------------------- 
 Telephone number:      +44(0)207 148 1018 
                       ----------------------------------------------------------- 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

FEEUROBRKNAUAAA

(END) Dow Jones Newswires

December 11, 2019 02:00 ET (07:00 GMT)

1 Year Hvivo Chart

1 Year Hvivo Chart

1 Month Hvivo Chart

1 Month Hvivo Chart

Your Recent History

Delayed Upgrade Clock